0001209191-23-016979.txt : 20230307 0001209191-23-016979.hdr.sgml : 20230307 20230307194855 ACCESSION NUMBER: 0001209191-23-016979 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230303 FILED AS OF DATE: 20230307 DATE AS OF CHANGE: 20230307 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Jiang Wenbin CENTRAL INDEX KEY: 0001872873 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40632 FILM NUMBER: 23714481 MAIL ADDRESS: STREET 1: C/O CYTEK BIOSCIENCES, INC. STREET 2: 46107 LANDING PARKWAY CITY: FREMONT STATE: CA ZIP: 94538 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cytek Biosciences, Inc. CENTRAL INDEX KEY: 0001831915 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 472547526 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 47215 LAKEVIEW BOULEVARD CITY: FREMONT STATE: CA ZIP: 94538 BUSINESS PHONE: (877) 922-9835 MAIL ADDRESS: STREET 1: 47215 LAKEVIEW BOULEVARD CITY: FREMONT STATE: CA ZIP: 94538 FORMER COMPANY: FORMER CONFORMED NAME: Cytek BioSciences, Inc. DATE OF NAME CHANGE: 20201110 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2023-03-03 0 0001831915 Cytek Biosciences, Inc. CTKB 0001872873 Jiang Wenbin C/O CYTEK BIOSCIENCES, INC. 47215 LAKEVIEW BOULEVARD FREMONT CA 94538 1 1 0 0 President and CEO Common Stock 2023-03-07 4 S 0 20000 10.13 D 7704439 D Employee Stock Option (Right to Buy) 10.61 2023-03-03 4 A 0 284900 0.00 A 2033-03-03 Common Stock 284900 284900 D Restricted Stock Units 2023-03-03 4 A 0 188501 0.00 A Common Stock 188501 188501 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2022. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.00 to $10.33, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. 1/48th of the shares subject to the option shall vest monthly over four years from the vesting commencement date of March 3, 2023. The option becomes fully vested on March 3, 2027. Each Restricted Stock Unit (the "RSU Award") represents a contingent right to receive one share of the Issuer's common stock. The shares subject to the RSU Award shall vest over 4 years with 2/48 of the total shares underlying the RSU Award vesting on May 18, 2023 and each May 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on August 18, 2023 and each August 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on November 18, 2023 and each November 18 thereafter; and 4/48 of the total shares underlying the RSU Award vesting each March 10, 2024 and each March 10 thereafter, until fully vested. /s/ Valerie Barnett, Attorney-in-Fact for Wenbin Jiang 2023-03-07